As an early Christmas present for some, Chile and Mexico began vaccinations on Thursday after granting emergency approval for the Pfizer / BioNTech vaccine. But in Brazil, where the death toll from Covid-19 is much higher, life-saving vaccinations could be out of reach for months – the country’s Ministry of Health announced last week that the vaccinations would begin in February 2021.
Because Brazil has a strong track record of nationwide vaccination, she says the general expectation was that Brazilians would have a regional advantage in the fight against the pandemic.
“Brazil has always been the leader in the implementation of new vaccines. We manage to achieve a high vaccination coverage, even though it is a continental country with very different regions, such as São Paulo with a high population density and Amazonas, with huge distances, (and) an indigenous people, ”she said.
“People expected the Brazilian vaccination program to start sooner,” she said. But “other countries of America that have prepared are already starting the vaccination, and Brazil is lagging behind.”
With more than 7.4 million people diagnosed with Covid-19 in Brazil and new variants of the virus emerging abroad, there is little reason to believe the pandemic is on the wane – a claim Bolsonaro made this year repeatedly did, even as the number of cases continued to increase. in the country. Only the US and India report more coronavirus infections than Brazil.
The Brazilian president also made headlines last week with a bizarre attempt to cast doubt on possible side effects of the Pfizer vaccine. “If you become an alligator, that’s your problem,” he warned. “If you become Superman, or grow a beard as a woman, or a man’s voice gets high, I have nothing to do with that … or worse, you disrupt people’s immune systems.”
Pfizer did not respond to CNN’s request for comment.
Domingues believes Brazil’s federal government was caught unprepared to use the Pfizer / BioNTech vaccine after lending its support to a vaccine candidate from Oxford University and AstraZeneca, who have partnered with the local Fiocruz foundation. Brazil has agreed to acquire more than 100 million doses of that vaccine, which is still under development, according to a statement published by the Ministry of Health last week.
Meanwhile, fears persist over the influence of politics on the process, after a year of bitter clashes between Bolsonaro and state governors over the country’s pandemic response.
The president has made no secret of his preference for the Oxford / AstraZeneca vaccine over a vaccine developed by Chinese maker Sinovac Biotech, which is supported by the state of Sao Paulo and developed locally with the Brazilian Butantan Institute .
ANVISA and the Brazilian Ministry of Health have not responded to requests for comment.
Reporting contributed by Tatiana Arias, Jennifer Z. Deaton, Natalie Gallon and Stefano Pozzebon.